-
- Irene Jarana Aparicio, Javier De Miguel Díez, Rodrigo Jimenez García, Julio César Vargas Espinal, Milagros Llanos Flores, Alicia Oliva Ramos, Valentín Hernández Barrera, and Pilar Carrasco Garrido.
- Chest. 2014 Mar 1;145(3 Suppl):21A.
Session TitleAsthmaSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 12:15 PM - 01:15 PMPURPOSE: To assess the changes in incidence, length of stay (LOS) and costs of patients hospitalized for asthma exacerbations (AE), between 2002 and 2010.MethodsWe included patients hospitalized for AE between 2002 and 2010 (ICD9-CM codes 493.0x-493.9x). We analyze, on the one hand, pediatric patients (0-15 years old) and, on the other hand, young adults (16-45 years old).The data were collected from the National Hospital Discharge Database (entire population). We analyzed the incidence, LOS and costs per patient in the two groups from 2002 to 2010.ResultsWe included a total of 12,038 pediatric patients and 2,792 young adults with AE. Overall crude incidence decreased from 20.5 to 18.7 AE per 100.000 inhabitants in the pediatric group (p<0.05), and also decreased from 4.12 to 3.68 AE per 100.000 inhabitants in the adult group, from 2002 to 2010 (p<0.05). The mean LOS decreased progressively in both groups during the study period, from 3.71 (SD 2.28) to 3.16 (SD 2.11) days in the pediatric group and from 5.36 (SD 4.02) to 5.16 (SD 5.39) days in the adult group, from 2002 to 2010 (p<0.05). During the study period, the mean cost per patient decreased from 1558.53 (SD 443.63) to 1378.41 (SD 472.71) euros in the pediatric group (p<0.05), while it increased from 2183.44 (SD 783.15) to 2564.32 (SD 1933.98) euros in the adult group (p<0.05).ConclusionsOur results suggest a decrease in the incidence of hospital admissions for AE with concomitant decrease in LOS in asthmatic patients, both in pediatric age as young adults. Although the mean cost has decreased in pediatric patients group, in young adults group has increased.Clinical ImplicationsBetter management of disease may explain the improvement in the incidence and outcomes.DisclosureThe following authors have nothing to disclose: Irene Jarana Aparicio, Javier De Miguel Díez, Rodrigo Jimenez García, Julio César Vargas Espinal, Milagros Llanos Flores, Alicia Oliva Ramos, Valentín Hernández Barrera, Pilar Carrasco GarridoNo Product/Research Disclosure Information.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.